logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onPlatformsJoin us
 
HRS4R
Summer training
Job offers
Global Compact
Training Program
foto principal

Xenopat launches website

Xenopat is a spin-off company of the Catalan Institute of Oncology (ICO), the Institute of Biomedical Research of Bellvitge (IDIBELL) and the University Hospital of Bellvitge (HUB). Created in September 2014, it provides customized mouse models for cancer treatment. Now it has launched its website: www.xenopat.com

[+info]
Register
User
Password

Accept

Shortcut
Calendar RSS Calendar
fletxa petita esquerraSeptember 2015fletxa petita dreta
MoTuWeThFrSaSu
123456
78910111213
14151617181920
21222324252627
282930
Follow us
Fabebook Twitter RSS Youtube channel
 
logo GENCAT logo UB logo hospital bellvitge
logo europa
logo europa2
logo ERC
logo ICS logo ICO logo hopsital viladecans
logo Mineco logo ISCIII logo ISCIII
 
© 2015 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




You have not yet answered the Human Resources Strategy for Research survey. It will not take you more than five minutes. Your opinion is very important to improve IDIBELL.

Do you want to complete the survey now?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No